कृपया अन्य खोज का प्रयास करें
चिन्ह | एक्सचेंज | करेंसी | ||
---|---|---|---|---|
4519 | टोक्यो | JPY | देरी | |
CHGCY | OTC Markets | USD | देरी | |
4519 | फ़्रंकफ़र्ट | EUR | देरी |
Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company's products for oncology primarily include Avastin, FoundationOne, Polivy, Rozlytrek, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, and Gazyva; Edirol, an Osteoporosis agent; Mircera, an erythropoiesis agent; Oxarol, an agent for secondary hyperparathyroidism; and other diseases comprise Hemlibra, CellCept, Bonviva, Tamiflu, Evrysdi, Ronapreve, Vabysmo, and Enspryng. It has various development product candidates in the areas of oncology, immunology, neuroscience, hematology, ophthalmology, and other diseases. Chugai Pharmaceutical Co., Ltd. has strategic alliances and collaboration with Roche Group. The company was founded in 1925 and is headquartered in Chuo, Japan. Chugai Pharmaceutical Co., Ltd. operates as a subsidiary of Roche Holding Ltd.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Osamu Nagayama | 75 | 1989 | Honorary Chairman & Senior Advisor |
Osamu Okuda | 59 | 2014 | President, CEO & Representative Director |
Henry L. Nordhoff | 81 | - | Chairman of the International Advisory Council |
Victor Halberstadt | - | - | Member of the International Advisory Council |
Franz Bernhard Humer | 77 | 2014 | Member of the International Advisory Council |
Andrew C. von Eschenbach | 81 | - | Member of the International Advisory Council |
Sonosuke Kadonaga | 71 | - | Member of the International Advisory Council |
William A. M. Burns | 76 | - | Member of the International Advisory Council |
Virginia Hilda Brunette Maxwell Bottomley | 75 | - | Member of the International Advisory Council |
Andre S. Hoffmann | 65 | - | Member of the International Advisory Council |
Arnold J. Levine | 83 | - | Member of the International Advisory Council |
Christoph Franz | 63 | 2017 | Non-Executive Director |
Fumio Tateishi | 74 | 2023 | Outside Independent Director |
Teresa A. Graham | 50 | 2023 | Director |
Hideo Teramoto | 63 | 2023 | Outside Independent Director |
Mariko Y. Momoi | 75 | 2020 | Outside Independent Non-Executive Director |
James H. Sabry | 65 | 2019 | Non-Executive Director |
Iwaaki Taniguchi | 57 | 2022 | Senior VP and Head of Finance, Accounting Dept. and Finance Supervisory Division & Director |
Yoshiaki Ohashi | 64 | 2015 | SVP & Full-time Audit Supervisory Board Member |
Shigehiro Yamada | 60 | 2023 | Head of Sustainability Department and Full-Time Audit & Supervisory Board Member |
Hitoshi Iikura | 54 | 2024 | VP, Head of Research Division & Director |
Kenichi Masuda | 61 | 2020 | Outside Independent Audit & Supervisory Board Member |
Mami Yunoki | 61 | 2024 | Audit & Supervisory Board Member |
Yumiko Waseda | 64 | 2023 | Outside Independent Audit & Supervisory Board Member |
Hitoshi Itakura | 54 | - | Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है